nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Gefitinib—lung cancer	0.131	0.32	CbGbCtD
Carteolol—CYP2D6—Vinorelbine—lung cancer	0.101	0.246	CbGbCtD
Carteolol—CYP2D6—Erlotinib—lung cancer	0.0774	0.189	CbGbCtD
Carteolol—CYP2D6—Vinblastine—lung cancer	0.0622	0.152	CbGbCtD
Carteolol—CYP2D6—Doxorubicin—lung cancer	0.0382	0.0933	CbGbCtD
Carteolol—Respiratory failure—Crizotinib—lung cancer	0.00953	0.0184	CcSEcCtD
Carteolol—Lacrimation increased—Pemetrexed—lung cancer	0.00928	0.0179	CcSEcCtD
Carteolol—Photophobia—Crizotinib—lung cancer	0.00879	0.017	CcSEcCtD
Carteolol—Respiratory failure—Pemetrexed—lung cancer	0.00871	0.0168	CcSEcCtD
Carteolol—Respiratory failure—Gefitinib—lung cancer	0.00866	0.0167	CcSEcCtD
Carteolol—Keratitis—Erlotinib—lung cancer	0.00783	0.0151	CcSEcCtD
Carteolol—Visual disturbance—Crizotinib—lung cancer	0.00717	0.0139	CcSEcCtD
Carteolol—Rash generalised—Paclitaxel—lung cancer	0.00695	0.0134	CcSEcCtD
Carteolol—Diplopia—Crizotinib—lung cancer	0.00679	0.0131	CcSEcCtD
Carteolol—Cerebrovascular accident—Pemetrexed—lung cancer	0.00634	0.0122	CcSEcCtD
Carteolol—Lacrimation—Irinotecan—lung cancer	0.00616	0.0119	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—lung cancer	0.00589	0.0114	CcSEcCtD
Carteolol—Diabetic—Methotrexate—lung cancer	0.00541	0.0105	CcSEcCtD
Carteolol—Respiratory failure—Topotecan—lung cancer	0.00523	0.0101	CcSEcCtD
Carteolol—Photophobia—Vinblastine—lung cancer	0.00496	0.00959	CcSEcCtD
Carteolol—Bradycardia—Crizotinib—lung cancer	0.00479	0.00925	CcSEcCtD
Carteolol—Conjunctivitis—Pemetrexed—lung cancer	0.00465	0.00899	CcSEcCtD
Carteolol—Conjunctivitis—Gefitinib—lung cancer	0.00462	0.00893	CcSEcCtD
Carteolol—Keratitis—Paclitaxel—lung cancer	0.00456	0.0088	CcSEcCtD
Carteolol—Visual impairment—Crizotinib—lung cancer	0.00453	0.00875	CcSEcCtD
Carteolol—Respiratory failure—Vinorelbine—lung cancer	0.00447	0.00865	CcSEcCtD
Carteolol—Bronchospasm—Teniposide—lung cancer	0.00428	0.00826	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—lung cancer	0.00426	0.00823	CcSEcCtD
Carteolol—Arrhythmia—Crizotinib—lung cancer	0.0042	0.00812	CcSEcCtD
Carteolol—Dysgeusia—Crizotinib—lung cancer	0.00401	0.00774	CcSEcCtD
Carteolol—Lacrimation increased—Irinotecan—lung cancer	0.00393	0.0076	CcSEcCtD
Carteolol—Cerebrovascular accident—Vinblastine—lung cancer	0.00392	0.00757	CcSEcCtD
Carteolol—Vision blurred—Crizotinib—lung cancer	0.00386	0.00745	CcSEcCtD
Carteolol—Arrhythmia—Pemetrexed—lung cancer	0.00384	0.00742	CcSEcCtD
Carteolol—Arrhythmia—Gefitinib—lung cancer	0.00381	0.00737	CcSEcCtD
Carteolol—Cerebrovascular accident—Erlotinib—lung cancer	0.00376	0.00727	CcSEcCtD
Carteolol—Syncope—Crizotinib—lung cancer	0.00367	0.00709	CcSEcCtD
Carteolol—Dysgeusia—Pemetrexed—lung cancer	0.00366	0.00708	CcSEcCtD
Carteolol—Loss of consciousness—Crizotinib—lung cancer	0.0036	0.00695	CcSEcCtD
Carteolol—Respiratory failure—Gemcitabine—lung cancer	0.00359	0.00695	CcSEcCtD
Carteolol—Eye irritation—Paclitaxel—lung cancer	0.00346	0.00669	CcSEcCtD
Carteolol—Syncope—Pemetrexed—lung cancer	0.00335	0.00648	CcSEcCtD
Carteolol—Oedema—Crizotinib—lung cancer	0.00334	0.00645	CcSEcCtD
Carteolol—Loss of consciousness—Pemetrexed—lung cancer	0.00329	0.00635	CcSEcCtD
Carteolol—Shock—Crizotinib—lung cancer	0.00329	0.00635	CcSEcCtD
Carteolol—Cerebrovascular accident—Vinorelbine—lung cancer	0.00325	0.00629	CcSEcCtD
Carteolol—Lacrimation increased—Paclitaxel—lung cancer	0.00321	0.0062	CcSEcCtD
Carteolol—Arrhythmia—Teniposide—lung cancer	0.00311	0.00601	CcSEcCtD
Carteolol—Oedema—Pemetrexed—lung cancer	0.00305	0.0059	CcSEcCtD
Carteolol—Atrioventricular block—Paclitaxel—lung cancer	0.00305	0.00589	CcSEcCtD
Carteolol—Respiratory failure—Paclitaxel—lung cancer	0.00301	0.00582	CcSEcCtD
Carteolol—Shock—Pemetrexed—lung cancer	0.003	0.0058	CcSEcCtD
Carteolol—Shock—Gefitinib—lung cancer	0.00298	0.00577	CcSEcCtD
Carteolol—Dyspnoea—Crizotinib—lung cancer	0.00298	0.00575	CcSEcCtD
Carteolol—Depression—Vinblastine—lung cancer	0.00295	0.0057	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—lung cancer	0.00293	0.00567	CcSEcCtD
Carteolol—Depression—Erlotinib—lung cancer	0.00283	0.00548	CcSEcCtD
Carteolol—Hypotension—Gefitinib—lung cancer	0.00283	0.00548	CcSEcCtD
Carteolol—Cardiac failure congestive—Gemcitabine—lung cancer	0.00283	0.00546	CcSEcCtD
Carteolol—Visual disturbance—Irinotecan—lung cancer	0.00278	0.00536	CcSEcCtD
Carteolol—Conjunctivitis—Erlotinib—lung cancer	0.00276	0.00534	CcSEcCtD
Carteolol—Dyspnoea—Pemetrexed—lung cancer	0.00272	0.00526	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—lung cancer	0.00272	0.00525	CcSEcCtD
Carteolol—Bronchospasm—Vinorelbine—lung cancer	0.00271	0.00524	CcSEcCtD
Carteolol—Dyspnoea—Gefitinib—lung cancer	0.0027	0.00522	CcSEcCtD
Carteolol—Cerebrovascular accident—Irinotecan—lung cancer	0.00268	0.00519	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—lung cancer	0.00266	0.00514	CcSEcCtD
Carteolol—Cardiac failure congestive—Cisplatin—lung cancer	0.00263	0.00509	CcSEcCtD
Carteolol—Cerebrovascular accident—Gemcitabine—lung cancer	0.00261	0.00505	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—lung cancer	0.00255	0.00493	CcSEcCtD
Carteolol—Oedema—Teniposide—lung cancer	0.00247	0.00478	CcSEcCtD
Carteolol—Cerebrovascular accident—Cisplatin—lung cancer	0.00244	0.00471	CcSEcCtD
Carteolol—Cardiac failure congestive—Etoposide—lung cancer	0.00241	0.00466	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—lung cancer	0.00241	0.00466	CcSEcCtD
Carteolol—Asthenia—Crizotinib—lung cancer	0.0024	0.00463	CcSEcCtD
Carteolol—Cardiac failure congestive—Paclitaxel—lung cancer	0.00237	0.00457	CcSEcCtD
Carteolol—Hypotension—Teniposide—lung cancer	0.00231	0.00446	CcSEcCtD
Carteolol—Arrhythmia—Erlotinib—lung cancer	0.00228	0.00441	CcSEcCtD
Carteolol—Visual disturbance—Paclitaxel—lung cancer	0.00226	0.00437	CcSEcCtD
Carteolol—Hypersensitivity—Pemetrexed—lung cancer	0.00225	0.00435	CcSEcCtD
Carteolol—Hypersensitivity—Gefitinib—lung cancer	0.00223	0.00432	CcSEcCtD
Carteolol—Dizziness—Crizotinib—lung cancer	0.00221	0.00427	CcSEcCtD
Carteolol—Dyspnoea—Teniposide—lung cancer	0.0022	0.00426	CcSEcCtD
Carteolol—Hypoglycaemia—Paclitaxel—lung cancer	0.0022	0.00425	CcSEcCtD
Carteolol—Asthenia—Pemetrexed—lung cancer	0.00219	0.00423	CcSEcCtD
Carteolol—Cerebrovascular accident—Paclitaxel—lung cancer	0.00219	0.00423	CcSEcCtD
Carteolol—Bronchospasm—Gemcitabine—lung cancer	0.00218	0.00421	CcSEcCtD
Carteolol—Asthenia—Gefitinib—lung cancer	0.00218	0.0042	CcSEcCtD
Carteolol—Dizziness—Pemetrexed—lung cancer	0.00202	0.0039	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—lung cancer	0.002	0.00387	CcSEcCtD
Carteolol—Syncope—Erlotinib—lung cancer	0.00199	0.00385	CcSEcCtD
Carteolol—Nausea—Crizotinib—lung cancer	0.00198	0.00383	CcSEcCtD
Carteolol—Arrhythmia—Vinorelbine—lung cancer	0.00197	0.00381	CcSEcCtD
Carteolol—Loss of consciousness—Erlotinib—lung cancer	0.00195	0.00377	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—lung cancer	0.00192	0.00371	CcSEcCtD
Carteolol—Bronchospasm—Etoposide—lung cancer	0.00186	0.00359	CcSEcCtD
Carteolol—Bradycardia—Irinotecan—lung cancer	0.00185	0.00358	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—lung cancer	0.00184	0.00355	CcSEcCtD
Carteolol—Hypersensitivity—Teniposide—lung cancer	0.00182	0.00352	CcSEcCtD
Carteolol—Oedema—Erlotinib—lung cancer	0.00181	0.0035	CcSEcCtD
Carteolol—Nausea—Pemetrexed—lung cancer	0.00181	0.0035	CcSEcCtD
Carteolol—Nausea—Gefitinib—lung cancer	0.0018	0.00348	CcSEcCtD
Carteolol—Conjunctivitis—Cisplatin—lung cancer	0.00179	0.00346	CcSEcCtD
Carteolol—Shock—Erlotinib—lung cancer	0.00178	0.00345	CcSEcCtD
Carteolol—Asthenia—Teniposide—lung cancer	0.00177	0.00343	CcSEcCtD
Carteolol—Visual impairment—Irinotecan—lung cancer	0.00175	0.00339	CcSEcCtD
Carteolol—Palpitations—Vinorelbine—lung cancer	0.0017	0.00328	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—lung cancer	0.0017	0.00328	CcSEcCtD
Carteolol—Bradycardia—Cisplatin—lung cancer	0.00168	0.00325	CcSEcCtD
Carteolol—Depression—Paclitaxel—lung cancer	0.00165	0.00319	CcSEcCtD
Carteolol—Insomnia—Erlotinib—lung cancer	0.00164	0.00317	CcSEcCtD
Carteolol—Dyspnoea—Topotecan—lung cancer	0.00163	0.00316	CcSEcCtD
Carteolol—Arrhythmia—Irinotecan—lung cancer	0.00163	0.00314	CcSEcCtD
Carteolol—Dyspnoea—Erlotinib—lung cancer	0.00162	0.00312	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—lung cancer	0.00161	0.00311	CcSEcCtD
Carteolol—Conjunctivitis—Paclitaxel—lung cancer	0.00161	0.00311	CcSEcCtD
Carteolol—Visual impairment—Cisplatin—lung cancer	0.00159	0.00308	CcSEcCtD
Carteolol—Arrhythmia—Gemcitabine—lung cancer	0.00158	0.00306	CcSEcCtD
Carteolol—Sinusitis—Paclitaxel—lung cancer	0.00155	0.003	CcSEcCtD
Carteolol—Headache—Teniposide—lung cancer	0.00155	0.00299	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—lung cancer	0.00155	0.00299	CcSEcCtD
Carteolol—Bradycardia—Paclitaxel—lung cancer	0.00151	0.00292	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—lung cancer	0.00151	0.00291	CcSEcCtD
Carteolol—Arrhythmia—Cisplatin—lung cancer	0.00148	0.00285	CcSEcCtD
Carteolol—Nausea—Teniposide—lung cancer	0.00147	0.00284	CcSEcCtD
Carteolol—Hypotension—Vinorelbine—lung cancer	0.00146	0.00283	CcSEcCtD
Carteolol—Visual impairment—Paclitaxel—lung cancer	0.00143	0.00276	CcSEcCtD
Carteolol—Syncope—Irinotecan—lung cancer	0.00142	0.00275	CcSEcCtD
Carteolol—Dyspnoea—Vinorelbine—lung cancer	0.0014	0.0027	CcSEcCtD
Carteolol—Loss of consciousness—Irinotecan—lung cancer	0.00139	0.00269	CcSEcCtD
Carteolol—Hypersensitivity—Vinblastine—lung cancer	0.00139	0.00269	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—lung cancer	0.00138	0.00267	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—lung cancer	0.00136	0.00263	CcSEcCtD
Carteolol—Vision blurred—Cisplatin—lung cancer	0.00136	0.00262	CcSEcCtD
Carteolol—Asthenia—Vinblastine—lung cancer	0.00135	0.00262	CcSEcCtD
Carteolol—Hypersensitivity—Topotecan—lung cancer	0.00135	0.00261	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—lung cancer	0.00134	0.00258	CcSEcCtD
Carteolol—Arrhythmia—Paclitaxel—lung cancer	0.00133	0.00256	CcSEcCtD
Carteolol—Asthenia—Topotecan—lung cancer	0.00131	0.00254	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—lung cancer	0.0013	0.00252	CcSEcCtD
Carteolol—Asthenia—Erlotinib—lung cancer	0.0013	0.00251	CcSEcCtD
Carteolol—Oedema—Irinotecan—lung cancer	0.00129	0.0025	CcSEcCtD
Carteolol—Dysgeusia—Etoposide—lung cancer	0.00129	0.00249	CcSEcCtD
Carteolol—Shock—Irinotecan—lung cancer	0.00127	0.00246	CcSEcCtD
Carteolol—Dysgeusia—Paclitaxel—lung cancer	0.00127	0.00244	CcSEcCtD
Carteolol—Oedema—Gemcitabine—lung cancer	0.00126	0.00243	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—lung cancer	0.00125	0.00242	CcSEcCtD
Carteolol—Dizziness—Vinblastine—lung cancer	0.00125	0.00241	CcSEcCtD
Carteolol—Vision blurred—Paclitaxel—lung cancer	0.00122	0.00235	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—lung cancer	0.00121	0.00234	CcSEcCtD
Carteolol—Dizziness—Topotecan—lung cancer	0.00121	0.00234	CcSEcCtD
Carteolol—Hypotension—Irinotecan—lung cancer	0.00121	0.00233	CcSEcCtD
Carteolol—Dizziness—Erlotinib—lung cancer	0.0012	0.00232	CcSEcCtD
Carteolol—Headache—Vinblastine—lung cancer	0.00118	0.00228	CcSEcCtD
Carteolol—Hypotension—Gemcitabine—lung cancer	0.00118	0.00227	CcSEcCtD
Carteolol—Oedema—Cisplatin—lung cancer	0.00117	0.00227	CcSEcCtD
Carteolol—Insomnia—Irinotecan—lung cancer	0.00117	0.00226	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—lung cancer	0.00116	0.00225	CcSEcCtD
Carteolol—Syncope—Paclitaxel—lung cancer	0.00116	0.00224	CcSEcCtD
Carteolol—Loss of consciousness—Etoposide—lung cancer	0.00116	0.00224	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—lung cancer	0.00116	0.00224	CcSEcCtD
Carteolol—Hypersensitivity—Vinorelbine—lung cancer	0.00115	0.00223	CcSEcCtD
Carteolol—Dyspnoea—Irinotecan—lung cancer	0.00115	0.00223	CcSEcCtD
Carteolol—Headache—Topotecan—lung cancer	0.00115	0.00222	CcSEcCtD
Carteolol—Palpitations—Paclitaxel—lung cancer	0.00114	0.00221	CcSEcCtD
Carteolol—Insomnia—Gemcitabine—lung cancer	0.00114	0.0022	CcSEcCtD
Carteolol—Headache—Erlotinib—lung cancer	0.00114	0.00219	CcSEcCtD
Carteolol—Loss of consciousness—Paclitaxel—lung cancer	0.00114	0.00219	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—lung cancer	0.00113	0.00219	CcSEcCtD
Carteolol—Asthenia—Vinorelbine—lung cancer	0.00112	0.00217	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—lung cancer	0.00112	0.00217	CcSEcCtD
Carteolol—Dyspnoea—Gemcitabine—lung cancer	0.00112	0.00217	CcSEcCtD
Carteolol—Nausea—Vinblastine—lung cancer	0.00112	0.00217	CcSEcCtD
Carteolol—Hypotension—Cisplatin—lung cancer	0.0011	0.00212	CcSEcCtD
Carteolol—Nausea—Topotecan—lung cancer	0.00109	0.0021	CcSEcCtD
Carteolol—Nausea—Erlotinib—lung cancer	0.00108	0.00208	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—lung cancer	0.00107	0.00207	CcSEcCtD
Carteolol—Oedema—Paclitaxel—lung cancer	0.00105	0.00204	CcSEcCtD
Carteolol—Dyspnoea—Cisplatin—lung cancer	0.00105	0.00202	CcSEcCtD
Carteolol—Shock—Paclitaxel—lung cancer	0.00104	0.002	CcSEcCtD
Carteolol—Dizziness—Vinorelbine—lung cancer	0.00104	0.002	CcSEcCtD
Carteolol—Depression—Methotrexate—lung cancer	0.00101	0.00195	CcSEcCtD
Carteolol—Hypotension—Etoposide—lung cancer	0.001	0.00194	CcSEcCtD
Carteolol—Hypotension—Paclitaxel—lung cancer	0.000985	0.0019	CcSEcCtD
Carteolol—Headache—Vinorelbine—lung cancer	0.000982	0.0019	CcSEcCtD
Carteolol—Syncope—Docetaxel—lung cancer	0.000982	0.0019	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—lung cancer	0.000982	0.0019	CcSEcCtD
Carteolol—Palpitations—Docetaxel—lung cancer	0.000968	0.00187	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—lung cancer	0.000962	0.00186	CcSEcCtD
Carteolol—Dyspnoea—Etoposide—lung cancer	0.000959	0.00185	CcSEcCtD
Carteolol—Insomnia—Paclitaxel—lung cancer	0.000954	0.00184	CcSEcCtD
Carteolol—Hypersensitivity—Irinotecan—lung cancer	0.000952	0.00184	CcSEcCtD
Carteolol—Dyspnoea—Paclitaxel—lung cancer	0.00094	0.00182	CcSEcCtD
Carteolol—Nausea—Vinorelbine—lung cancer	0.000931	0.0018	CcSEcCtD
Carteolol—Asthenia—Irinotecan—lung cancer	0.000927	0.00179	CcSEcCtD
Carteolol—Asthenia—Gemcitabine—lung cancer	0.000903	0.00175	CcSEcCtD
Carteolol—Oedema—Docetaxel—lung cancer	0.000894	0.00173	CcSEcCtD
Carteolol—Shock—Docetaxel—lung cancer	0.000879	0.0017	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—lung cancer	0.000874	0.00169	CcSEcCtD
Carteolol—Hypersensitivity—Cisplatin—lung cancer	0.000865	0.00167	CcSEcCtD
Carteolol—Dizziness—Irinotecan—lung cancer	0.000855	0.00165	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—lung cancer	0.00085	0.00164	CcSEcCtD
Carteolol—Asthenia—Cisplatin—lung cancer	0.000842	0.00163	CcSEcCtD
Carteolol—Hypotension—Docetaxel—lung cancer	0.000835	0.00161	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—lung cancer	0.00082	0.00159	CcSEcCtD
Carteolol—Headache—Irinotecan—lung cancer	0.00081	0.00157	CcSEcCtD
Carteolol—Insomnia—Docetaxel—lung cancer	0.000808	0.00156	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—lung cancer	0.000799	0.00154	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—lung cancer	0.000797	0.00154	CcSEcCtD
Carteolol—Hypersensitivity—Etoposide—lung cancer	0.000792	0.00153	CcSEcCtD
Carteolol—Headache—Gemcitabine—lung cancer	0.000789	0.00152	CcSEcCtD
Carteolol—Hypersensitivity—Paclitaxel—lung cancer	0.000777	0.0015	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—lung cancer	0.000773	0.00149	CcSEcCtD
Carteolol—Asthenia—Etoposide—lung cancer	0.000771	0.00149	CcSEcCtD
Carteolol—Nausea—Irinotecan—lung cancer	0.000768	0.00148	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—lung cancer	0.000756	0.00146	CcSEcCtD
Carteolol—Asthenia—Paclitaxel—lung cancer	0.000756	0.00146	CcSEcCtD
Carteolol—Nausea—Gemcitabine—lung cancer	0.000748	0.00145	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—lung cancer	0.000744	0.00144	CcSEcCtD
Carteolol—Dizziness—Etoposide—lung cancer	0.000711	0.00137	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—lung cancer	0.000701	0.00136	CcSEcCtD
Carteolol—Dizziness—Paclitaxel—lung cancer	0.000697	0.00135	CcSEcCtD
Carteolol—Nausea—Cisplatin—lung cancer	0.000697	0.00135	CcSEcCtD
Carteolol—Headache—Etoposide—lung cancer	0.000674	0.0013	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—lung cancer	0.000669	0.00129	CcSEcCtD
Carteolol—Headache—Paclitaxel—lung cancer	0.00066	0.00128	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—lung cancer	0.000658	0.00127	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—lung cancer	0.000644	0.00124	CcSEcCtD
Carteolol—Asthenia—Docetaxel—lung cancer	0.000641	0.00124	CcSEcCtD
Carteolol—Nausea—Etoposide—lung cancer	0.000639	0.00123	CcSEcCtD
Carteolol—Nausea—Paclitaxel—lung cancer	0.000626	0.00121	CcSEcCtD
Carteolol—Syncope—Doxorubicin—lung cancer	0.000613	0.00118	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—lung cancer	0.000604	0.00117	CcSEcCtD
Carteolol—Hypotension—Methotrexate—lung cancer	0.000602	0.00116	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—lung cancer	0.000601	0.00116	CcSEcCtD
Carteolol—Dizziness—Docetaxel—lung cancer	0.000591	0.00114	CcSEcCtD
Carteolol—Insomnia—Methotrexate—lung cancer	0.000583	0.00113	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—lung cancer	0.000574	0.00111	CcSEcCtD
Carteolol—Headache—Docetaxel—lung cancer	0.00056	0.00108	CcSEcCtD
Carteolol—Oedema—Doxorubicin—lung cancer	0.000558	0.00108	CcSEcCtD
Carteolol—Shock—Doxorubicin—lung cancer	0.000549	0.00106	CcSEcCtD
Carteolol—Nausea—Docetaxel—lung cancer	0.000531	0.00103	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—lung cancer	0.000521	0.00101	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—lung cancer	0.000504	0.000975	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—lung cancer	0.000497	0.000961	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—lung cancer	0.000475	0.000917	CcSEcCtD
Carteolol—Asthenia—Methotrexate—lung cancer	0.000462	0.000893	CcSEcCtD
Carteolol—Dizziness—Methotrexate—lung cancer	0.000426	0.000823	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—lung cancer	0.000411	0.000794	CcSEcCtD
Carteolol—Headache—Methotrexate—lung cancer	0.000403	0.00078	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—lung cancer	0.0004	0.000773	CcSEcCtD
Carteolol—Nausea—Methotrexate—lung cancer	0.000383	0.000739	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—lung cancer	0.000369	0.000713	CcSEcCtD
Carteolol—Headache—Doxorubicin—lung cancer	0.000349	0.000675	CcSEcCtD
Carteolol—Nausea—Doxorubicin—lung cancer	0.000331	0.00064	CcSEcCtD
Carteolol—Nadolol—ABCB1—lung cancer	0.000254	0.503	CrCbGaD
Carteolol—Propranolol—CYP1A1—lung cancer	0.000164	0.325	CrCbGaD
Carteolol—Propranolol—ABCB1—lung cancer	8.7e-05	0.173	CrCbGaD
Carteolol—CYP2D6—Biological oxidations—POMC—lung cancer	8.22e-05	0.00113	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ANXA1—lung cancer	8.11e-05	0.00112	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRM8—lung cancer	8.08e-05	0.00111	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	8.04e-05	0.00111	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—POMC—lung cancer	7.91e-05	0.00109	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRM8—lung cancer	7.91e-05	0.00109	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	7.86e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—APP—lung cancer	7.86e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SKI—lung cancer	7.83e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—POMC—lung cancer	7.74e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—APP—lung cancer	7.69e-05	0.00106	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SKI—lung cancer	7.66e-05	0.00106	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLBD1—lung cancer	7.35e-05	0.00101	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PXN—lung cancer	6.8e-05	0.000938	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AVP—lung cancer	6.73e-05	0.000928	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD17B10—lung cancer	6.72e-05	0.000927	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—OXTR—lung cancer	6.66e-05	0.000918	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKR1C1—lung cancer	6.66e-05	0.000918	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRP—lung cancer	6.66e-05	0.000918	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PXN—lung cancer	6.65e-05	0.000917	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AVP—lung cancer	6.58e-05	0.000908	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRP—lung cancer	6.51e-05	0.000898	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—OXTR—lung cancer	6.51e-05	0.000898	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKR1C1—lung cancer	6.51e-05	0.000898	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CKB—lung cancer	6.25e-05	0.000862	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNG11—lung cancer	6.23e-05	0.000859	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CXCL8—lung cancer	6.12e-05	0.000844	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AVP—lung cancer	6.11e-05	0.000843	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNG11—lung cancer	6.1e-05	0.000841	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CXCL8—lung cancer	5.99e-05	0.000826	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AVP—lung cancer	5.98e-05	0.000825	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFC—lung cancer	5.93e-05	0.000818	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM2—lung cancer	5.87e-05	0.00081	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CNDP2—lung cancer	5.87e-05	0.00081	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFC—lung cancer	5.8e-05	0.000801	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTMR3—lung cancer	5.72e-05	0.000788	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADCY1—lung cancer	5.6e-05	0.000773	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PGAM1—lung cancer	5.57e-05	0.000768	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADCY1—lung cancer	5.48e-05	0.000756	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP2R1B—lung cancer	5.46e-05	0.000753	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SMARCA4—lung cancer	5.46e-05	0.000753	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP2R1B—lung cancer	5.34e-05	0.000737	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SMARCA4—lung cancer	5.34e-05	0.000737	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2A7—lung cancer	5.31e-05	0.000733	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HSPB1—lung cancer	5.27e-05	0.000727	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTHLH—lung cancer	5.21e-05	0.000718	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SDC4—lung cancer	5.2e-05	0.000717	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HSPB1—lung cancer	5.15e-05	0.000711	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTHLH—lung cancer	5.1e-05	0.000703	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ANXA1—lung cancer	4.9e-05	0.000676	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ANXA1—lung cancer	4.79e-05	0.000661	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FLT1—lung cancer	4.74e-05	0.000654	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—RRM1—lung cancer	4.74e-05	0.000653	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA3—lung cancer	4.74e-05	0.000653	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—lung cancer	4.7e-05	0.000648	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APP—lung cancer	4.64e-05	0.00064	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH3—lung cancer	4.64e-05	0.00064	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FLT1—lung cancer	4.64e-05	0.00064	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF9—lung cancer	4.6e-05	0.000635	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	4.6e-05	0.000634	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APP—lung cancer	4.54e-05	0.000626	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH3—lung cancer	4.54e-05	0.000626	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF9—lung cancer	4.5e-05	0.000621	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—POMC—lung cancer	4.47e-05	0.000617	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—B4GALT5—lung cancer	4.45e-05	0.000614	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUNB—lung cancer	4.4e-05	0.000606	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—POMC—lung cancer	4.38e-05	0.000603	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA4—lung cancer	4.33e-05	0.000597	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUNB—lung cancer	4.3e-05	0.000593	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	4.27e-05	0.000589	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA2—lung cancer	4.22e-05	0.000582	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	4.17e-05	0.000576	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	4.13e-05	0.00057	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA1—lung cancer	4.07e-05	0.000562	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—POMC—lung cancer	4.06e-05	0.00056	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	4.04e-05	0.000557	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCC3—lung cancer	4.03e-05	0.000555	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STK11—lung cancer	3.99e-05	0.000551	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—POMC—lung cancer	3.97e-05	0.000548	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	3.96e-05	0.000546	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STK11—lung cancer	3.91e-05	0.000539	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C1—lung cancer	3.9e-05	0.000538	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	3.88e-05	0.000535	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	3.85e-05	0.000531	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UGT1A1—lung cancer	3.79e-05	0.000522	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	3.78e-05	0.000521	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.77e-05	0.00052	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	3.75e-05	0.000517	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.69e-05	0.000509	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.67e-05	0.000506	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNG11—lung cancer	3.65e-05	0.000504	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AVP—lung cancer	3.61e-05	0.000498	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	3.6e-05	0.000497	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AVP—lung cancer	3.53e-05	0.000487	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	3.52e-05	0.000486	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDOA—lung cancer	3.48e-05	0.000479	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	3.48e-05	0.000479	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	3.46e-05	0.000477	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HES1—lung cancer	3.41e-05	0.000471	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	3.4e-05	0.000469	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	3.38e-05	0.000467	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA3—lung cancer	3.37e-05	0.000465	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	3.35e-05	0.000462	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HES1—lung cancer	3.34e-05	0.000461	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	3.31e-05	0.000456	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADCY1—lung cancer	3.28e-05	0.000453	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG2—lung cancer	3.28e-05	0.000453	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	3.28e-05	0.000452	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	3.27e-05	0.000451	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	3.23e-05	0.000446	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HPGDS—lung cancer	3.22e-05	0.000444	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO2—lung cancer	3.22e-05	0.000444	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.2e-05	0.000441	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	3.2e-05	0.000441	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	3.14e-05	0.000433	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTT1—lung cancer	3.12e-05	0.000431	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	3.12e-05	0.000431	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCLC—lung cancer	3.09e-05	0.000426	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2A6—lung cancer	3.09e-05	0.000426	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	3.07e-05	0.000424	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	3.05e-05	0.000421	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL2—lung cancer	3e-05	0.000414	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TERT—lung cancer	2.99e-05	0.000413	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL2—lung cancer	2.94e-05	0.000405	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TERT—lung cancer	2.93e-05	0.000404	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO1—lung cancer	2.93e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	2.9e-05	0.000401	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	2.86e-05	0.000395	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.84e-05	0.000392	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.8e-05	0.000386	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—lung cancer	2.76e-05	0.000381	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—lung cancer	2.74e-05	0.000377	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—lung cancer	2.7e-05	0.000373	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—lung cancer	2.68e-05	0.000369	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2E1—lung cancer	2.62e-05	0.000362	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NQO1—lung cancer	2.59e-05	0.000358	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APC—lung cancer	2.52e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	2.52e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KIT—lung cancer	2.52e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	2.52e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGF—lung cancer	2.49e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APC—lung cancer	2.47e-05	0.00034	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.47e-05	0.00034	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KIT—lung cancer	2.47e-05	0.00034	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.47e-05	0.00034	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGF—lung cancer	2.44e-05	0.000336	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.41e-05	0.000333	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—POMC—lung cancer	2.4e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.37e-05	0.000327	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.36e-05	0.000326	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—POMC—lung cancer	2.35e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.34e-05	0.000323	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STK11—lung cancer	2.34e-05	0.000323	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.34e-05	0.000322	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.32e-05	0.00032	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.3e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6R—lung cancer	2.29e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2.29e-05	0.000315	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	2.25e-05	0.00031	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	2.23e-05	0.000308	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	2.22e-05	0.000306	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	2.19e-05	0.000303	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	2.18e-05	0.000301	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	2.17e-05	0.000299	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	2.17e-05	0.000299	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—lung cancer	2.16e-05	0.000299	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	2.15e-05	0.000296	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	2.12e-05	0.000293	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAT—lung cancer	2.11e-05	0.00029	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—lung cancer	2.05e-05	0.000283	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMS—lung cancer	2.01e-05	0.000278	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	1.99e-05	0.000275	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—lung cancer	1.99e-05	0.000274	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MDM2—lung cancer	1.99e-05	0.000274	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RAF1—lung cancer	1.98e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.96e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.95e-05	0.000269	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MDM2—lung cancer	1.94e-05	0.000268	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RAF1—lung cancer	1.94e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTOR—lung cancer	1.93e-05	0.000266	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.93e-05	0.000266	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.91e-05	0.000264	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.89e-05	0.000261	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.89e-05	0.000261	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.89e-05	0.00026	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ERCC2—lung cancer	1.87e-05	0.000258	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.86e-05	0.000256	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.84e-05	0.000254	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.82e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.8e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.79e-05	0.000247	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.78e-05	0.000245	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL2—lung cancer	1.77e-05	0.000245	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.76e-05	0.000243	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.75e-05	0.000242	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.74e-05	0.00024	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL2—lung cancer	1.74e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.73e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.73e-05	0.000238	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000238	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.69e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUN—lung cancer	1.69e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.68e-05	0.000232	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.67e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTEN—lung cancer	1.67e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.64e-05	0.000227	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.64e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.63e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.63e-05	0.000225	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—lung cancer	1.62e-05	0.000223	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.59e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EP300—lung cancer	1.59e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EP300—lung cancer	1.56e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—lung cancer	1.55e-05	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—lung cancer	1.51e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.51e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.49e-05	0.000206	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.49e-05	0.000205	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.48e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.47e-05	0.000203	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.46e-05	0.000201	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.46e-05	0.000201	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000197	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—POMC—lung cancer	1.41e-05	0.000194	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.39e-05	0.000192	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000191	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CREBBP—lung cancer	1.37e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—lung cancer	1.36e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.33e-05	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.3e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.28e-05	0.000177	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—lung cancer	1.28e-05	0.000177	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.25e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	0.000162	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.15e-05	0.000159	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—lung cancer	1.14e-05	0.000157	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.13e-05	0.000156	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—lung cancer	1.12e-05	0.000155	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—lung cancer	1.11e-05	0.000154	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.09e-05	0.00015	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.07e-05	0.000147	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—lung cancer	1.04e-05	0.000144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—lung cancer	1.02e-05	0.000141	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTEN—lung cancer	9.78e-06	0.000135	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—lung cancer	9.62e-06	0.000133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—lung cancer	9.41e-06	0.00013	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—EP300—lung cancer	9.32e-06	0.000129	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—lung cancer	6.9e-06	9.51e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—lung cancer	5.63e-06	7.77e-05	CbGpPWpGaD
